Official Journal
Login
Register
Home
About WMS
About WMS
About the WMS
A short history of the WMS
Committees
WMS Corporate Identity
World Muscle Society Charter
Current Executive Board
WMS Executive Board election 2025
Membership
Membership
WMS Membership
For Members
Membership Directory
Frequently Asked Questions (FAQ)
Join WMS
Membership Grant
Membership Values and Code of Conduct
Project Proposals
Feedback
NMD Updates
NMD Updates
Featured Cases
Gene Table
Guidelines
Myology Developments Across The World
News
Newsletter
Official Journal
Publication Highlights
WMS Community
WMS Community
Accessibility and the WMS
Awareness Days
Case Discussion Directory
Community Directory
Education & Development Opportunities
Events
Early-Mid Career Information
Job Opportunities
Knowledge Base
Mentorship Programme Directory
Myology Café
Obituaries
Patient Advocacy Group Directory
Regional Networks
Strengthening Education for Equity Development (SEED)
Useful Resources
Congress
Congress
Future WMS Meeting Locations and Dates
Fellowships and Prizes
Past World Muscle Society Congresses
Previous Prize Winners
Congress RFP
Contact Us
Contact Us
Contact Us
Complaints Procedure
Home
Guidelines
Delandistrogene Moxeparvovec Gen...
Delandistrogene Moxeparvovec Gene Therapy in Individuals With Duchenne Muscular Dystrophy: Evidence in Focus
Guidelines
Clinical
2025
Muscle
English
https://doi.org/10.1212/WNL.0000000000213604
WMS Facebook Feed
World Muscle Society
